Ładuje się......
Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
To assess the level of activity and toxicity of gefitinib (ZD1839, Iressa™) in a population of patients with locally recurrent and/or metastatic head and neck cancer. Patients were recruited into an expanded access programme through the multidisciplinary head and neck clinics at the Royal Marsden an...
Zapisane w:
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2006
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361202/ https://ncbi.nlm.nih.gov/pubmed/16495923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602999 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|